4//SEC Filing
Pinkas Jan 4
Accession 0001628280-25-057687
CIK 0001253689other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:49 PM ET
Size
8.9 KB
Accession
0001628280-25-057687
Insider Transaction Report
Form 4
Pinkas Jan
Chief Scientific Officer
Transactions
- Award
Ordinary Shares
2025-12-15+17,507→ 17,507 total - Award
Ordinary Shares
2025-12-15+5,000→ 22,507 total - Award
Stock Option (Right to Buy)
2025-12-15+70,025→ 70,025 totalExercise: $13.21Exp: 2035-12-15→ Ordinary Shares (70,025 underlying)
Footnotes (2)
- [F1]Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Ordinary Shares. The RSUs shall vest in approximately equal three-month installments through the four-year anniversary of December 15, 2025, subject to the Reporting Person remaining continuously employed by or providing services to the Issuer or its subsidiaries from December 15, 2025 through each such vesting date.
- [F2]This Option represents a right to purchase shares of the Issuer's Ordinary Shares and vests with respect to 1/48th of the Option on each monthly anniversary of December 15, 2025, subject to the Reporting Person remaining continuously employed by or providing services to the Issuer or its subsidiaries from December 15, 2025 through each such vesting date.
Documents
Issuer
CRESCENT BIOPHARMA, INC.
CIK 0001253689
Entity typeother
Related Parties
1- filerCIK 0002077126
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:49 PM ET
- Size
- 8.9 KB